(Q44114291)

English

Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis

scientific article published in August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis (English)

1 reference

Europe PubMed Central

29 November 2017

0 references

Christa E Müller

12

1 reference

Europe PubMed Central

29 November 2017

author name string

Ulrich Flögel

1

1 reference

Europe PubMed Central

29 November 2017

Sandra Burghoff

2

1 reference

Europe PubMed Central

29 November 2017

Peter L E M van Lent

3

1 reference

Europe PubMed Central

29 November 2017

Sebastian Temme

4

1 reference

Europe PubMed Central

29 November 2017

Lisa Galbarz

5

1 reference

Europe PubMed Central

29 November 2017

Zhaoping Ding

6

1 reference

Europe PubMed Central

29 November 2017

Ali El-Tayeb

7

1 reference

Europe PubMed Central

29 November 2017

Sandra Huels

8

1 reference

Europe PubMed Central

29 November 2017

Florian Bönner

9

1 reference

Europe PubMed Central

29 November 2017

Nadine Borg

10

1 reference

Europe PubMed Central

29 November 2017

Christoph Jacoby

11

1 reference

Europe PubMed Central

29 November 2017

Wim B van den Berg

13

1 reference

Europe PubMed Central

29 November 2017

Jürgen Schrader

14

1 reference

Europe PubMed Central

29 November 2017

language of work or name

0 references

publication date

1 August 2012

1 reference

Europe PubMed Central

29 November 2017

Science Translational Medicine

1 reference

Europe PubMed Central

29 November 2017

4

1 reference

Europe PubMed Central

29 November 2017

146

1 reference

Europe PubMed Central

29 November 2017

146ra108

1 reference

Europe PubMed Central

29 November 2017

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Revolutionary change in rheumatoid arthritis management with biological therapy

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Connexin37 protects against atherosclerosis by regulating monocyte adhesion

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Recent developments in adenosine receptor ligands and their potential as novel drugs

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Clinical utility of regadenoson for assessing fractional flow reserve.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Toll-like receptor 4 induced FcgammaR expression potentiates early onset of joint inflammation and cartilage destruction during immune complex arthritis: Toll-like receptor 4 largely regulates FcgammaR expression by interleukin 10.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

The role of adenosine receptors in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Hypoxia and inflammation

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Modeling the NF-κB mediated inflammatory response predicts cytokine waves in tissue

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Early assessment of pulmonary inflammation by 19F MRI in vivo

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future.

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Regulation of leukocyte function by adenosine receptors

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: Rationale for combination treatment during arthritis

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003717

21 January 2018

Identifiers

10.1126/SCITRANSLMED.3003717

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44114291&oldid=2106720599"